合成生物学の市場規模、シェア、動向分析レポート：製品別、技術別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

合成生物学市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の合成生物学市場規模は2030年までに420億6,000万米ドルに達し、2025年から2030年までのCAGRは17.30％を記録すると予測されています。

ワクチン研究を支援する政府および民間資金の存在と、臨床試験中の強力な合成生物学的ベースの製品パイプラインが市場の主要な促進要因です。合成生物学的プロセスは、疾患同定のための抗原や診断試薬の製造、ワクチン開発のスピードアップ、全体的なワクチンの性能と収率の向上に決定的な利点をもたらします。

さらに、政府機関からの支援や複数のプログラムの存在が、市場の成長を後押ししています。例えば米国では、COVID-19ワクチンの研究開発、製造、規制、購入は、Biomedical Advanced Research and Development Authority（BARDA）、National Institutes of Health（NIH）、DOD、FDA、その他（旧OWS）を含む連邦政府機関の協力によって高度に支援されています。

繊維や栄養などの産業における需要の拡大といったその他の要因も、市場の成長に寄与しています。合成生物学の助けを借りて、いくつかの最適な食品生産プロセスが特定されています。さらに、合成生物学は、より高い農業収量の創出や害虫駆除の開発に役立つと予測されています。より優れた食品収量の生産と害虫駆除管理に役立つことが期待されます。

COVID-19の大流行は市場成長にプラスの影響を与えると予想されます。合成生物学は、米国国立衛生研究所によってワクチン開発を加速させる手段として脚光を浴びています。そのため、合成生物学の研究所や企業は、COVID-19パンデミックに対抗するためにこの技術を積極的に活用しています。その結果、パンデミック発生中はこうした技術の利用が増加すると予測されます。

個別化医療に対する需要の高まりが、今後数年間の市場成長の大きな原動力になると予想されます。治療薬として使用するために設計された新規タンパク質の使用は、医療分野における合成生物学を実証しています。これらのタンパク質は、治療に必要な望ましい特性を得るために、タンパク質の構造をいくつか変更して設計されています。例えば、研究者はフェニルケトン尿症（PKU）を治療するために、消化管に安定で経口投与が可能な治療用酵素候補を開発しています。

その一方で、合成生物学はバイオセキュリティとバイオセーフティに関していくつかの懸念を引き起こしています。これらの製品に触れることで、公衆衛生や環境に未知の危険性が生じる可能性があるからです。このような問題を防ぐため、欧州、南北アメリカ、アジアの各国は、基礎・応用研究における合成生物学技術の応用を管理するための政策を策定しています。

合成生物学市場レポートハイライト

• 技術別では、PCR分野が市場で最大のシェアを占めています。これは、PCR技術が医学研究、ウイルス検出、飲食品産業など多くの分野で広く採用され、現代のライフサイエンスが加速度的に発展しているためです。
• ゲノム編集分野は予測期間中に安定した成長が見込まれます。これは、研究者が植物、細菌、動物を含む様々な生物のDNAを改変することを可能にし、その需要は今後数年で急増すると予想されます。
• 製品別では、2030年にはオリゴヌクレオチドおよび合成DNAの市場シェアが大きくなると予想されます。合成価格の低下と、多くの用途に使用される合成DNA、RNA、遺伝子への要求の高まりが、このセグメントの成長に寄与しています。
• 用途別では、ヘルスケア分野が世界市場で大きなシェアを占めています。これは、創薬スクリーニングや創薬の増加に起因します。さらに、合成生物学の利用は創薬コストを削減し、市場成長を促進します。
• 最終用途別では、バイオテクノロジーおよび製薬企業分野が2024年に大きなシェアを占めました。これは、近代的な研究施設の利用可能性が高まっていること、有利な法律、政府の援助や資金提供によるものです。
• 北米は、高い研究開発投資の存在、技術的に高度なヘルスケア研究枠組みの利用可能性、同地域における合成生物学市場の開拓により、2024年に支配的な市場に位置づけられました。
• アジア太平洋地域は、個別化治療の台頭と主要企業の存在により、今後かなりの成長が見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場見通し
• 市場動向と展望
• 市場力学
  • 合成生物学の応用の拡大
  • 政府と民間団体からの資金と支援の増加
  • 合成生物学における研究開発活動の拡大
• 市場抑制要因分析
  • バイオセーフティとバイオセキュリティの問題
  • 倫理的問題と予期せぬ結果
• 業界分析ツール
  • SWOT分析;要因別（政治・法律、経済・技術）
  • ポーターのファイブフォース分析
  • COVID-19の影響分析

第4章 製品のビジネス分析

• 製品セグメントダッシュボード
• 世界の合成生物学市場：製品変動分析
• 世界の合成生物学市場規模と動向分析、製品別、2018～2030年
• オリゴヌクレオチド/オリゴプールおよび合成DNA
  • オリゴヌクレオチド/オリゴプールおよび合成DNA市場、2018-2030年
• 酵素
  • 酵素市場、2018年-2030年
• クローニング技術キット
  • クローニング技術キット市場、2018年-2030年
• 異種核酸
  • 異種核酸市場、2018年-2030年
• シャーシ有機体
  • シャーシ有機体市場、2018年-2030年

第5章 技術のビジネス分析

• 技術セグメントダッシュボード
• 世界の合成生物学市場：技術変動分析
• 世界の合成生物学市場規模と動向分析、技術別、2018～2030年
• PCR
  • PCR市場、2018-2030
• ゲノム編集
  • ゲノム編集市場、2018年-2030年
• NGS
  • NGS市場、2018-2030
• バイオプロセス技術
  • バイオプロセス技術市場、2018年-2030年
• その他
  • その他市場、2018年-2030年

第6章 用途のビジネス分析

• 用途セグメントダッシュボード
• 世界の合成生物学市場：用途変動分析
• 世界の合成生物学市場規模と動向分析、用途別、2018～2030年
• 合成生物学市場：技術変動分析
• ヘルスケア
  • ヘルスケア市場、2018年-2030年
  • 臨床
  • 非臨床
• 非ヘルスケア
  • 非ヘルスケア市場、2018年-2030年
  • バイオテクノロジー作物
  • 特殊化学品
  • バイオ燃料
  • その他

第7章 最終用途のビジネス分析

• 最終用途セグメントダッシュボード
• 世界の合成生物学市場：最終用途変動分析
• 世界の合成生物学市場規模と動向分析、最終用途別、2018～2030年
• バイオテクノロジーおよび製薬企業
  • バイオテクノロジーおよび製薬企業市場、2018年-2030年
• 学術研究機関
  • 学術研究機関市場、2018年-2030年
• その他
  • その他市場、2018年-2030年

第8章 地域ビジネス分析

• 地域ダッシュボード
• 市場規模と予測および動向分析、2018年から2030年
• 北米
  • 北米合成生物学市場、2018年-2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州の合成生物学市場、2018年-2030年
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋地域の合成生物学市場、2018年-2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカの合成生物学市場、2018年-2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東・アフリカ合成生物学市場、2018-2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 参入企業
• 戦略マッピング
• 企業市況分析、2024年
• 参入企業の概要
  • Bota Biosciences Inc.
  • Codexis, Inc.
  • Creative Biogene
  • Creative Enzymes
  • Enbiotix, Inc.
  • Illumina, Inc.
  • Merck KGaA
  • New England Biolabs
  • Eurofins Scientific
  • Novozymes
  • Pareto Bio, Inc.
  • Scarab Genomics, Inc.
  • Synthego
  • Synthetic Genomics Inc.
  • Thermo Fisher Scientific, Inc.

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 4 Global Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 5 Global Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 6 Global Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 7 Global Synthetic Biology Market, by Region, 2018 - 2030 (USD Million)
• Table 8 North America Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
• Table 9 North America Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 10 North America Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 11 North America Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 12 North America Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 13 U.S. Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 14 U.S. Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 15 U.S. Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 16 U.S. Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 17 Canada Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 18 Canada Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 19 Canada Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 20 Canada Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 21 Mexico Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 22 Mexico Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 23 Mexico Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 24 Mexico Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 25 Europe Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
• Table 26 Europe Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 27 Europe Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 28 Europe Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 29 Europe Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 30 Germany Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 31 Germany Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 32 Germany Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 33 Germany Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 34 UK Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 35 UK Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 36 UK Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 37 UK Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 38 France Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 39 France Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 40 France Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 41 France Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 42 Italy Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 43 Italy Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 44 Italy Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 45 Italy Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 46 Spain Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 47 Spain Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 48 Spain Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 49 Spain Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 50 Denmark Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 51 Denmark Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 52 Denmark Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 53 Denmark Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 54 Sweden Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 55 Sweden Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 56 Sweden Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 57 Sweden Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 58 Norway Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 59 Norway Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 60 Norway Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 61 Norway Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 66 Asia Pacific Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 67 China Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 68 China Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 69 China Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 70 China Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 71 Japan Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 72 Japan Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 73 Japan Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 74 Japan Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 75 India Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 76 India Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 77 India Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 78 India Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 79 South Korea Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 80 South Korea Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 81 South Korea Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 82 South Korea Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 83 Australia Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 84 Australia Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 85 Australia Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 86 Australia Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 87 Thailand Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 88 Thailand Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 89 Thailand Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 90 Thailand Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 91 Latin America Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
• Table 92 Latin America Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 93 Latin America Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 94 Latin America Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 95 Latin America Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 96 Brazil Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 97 Brazil Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 98 Brazil Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 99 Brazil Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 100 Argentina Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 101 Argentina Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 102 Argentina Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 103 Argentina Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 104 Middle East & Africa Synthetic Biology Market, by Country, 2018 - 2030 (USD Million)
• Table 105 Middle East & Africa Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 106 Middle East & Africa Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 107 Middle East & Africa Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 108 Middle East & Africa Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 109 South Africa Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 110 South Africa Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 111 South Africa Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 112 South Africa Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 117 UAE Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 118 UAE Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 119 UAE Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 120 UAE Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)
• Table 121 Kuwait Synthetic Biology Market, by Product, 2018 - 2030 (USD Million)
• Table 122 Kuwait Synthetic Biology Market, by Technology, 2018 - 2030 (USD Million)
• Table 123 Kuwait Synthetic Biology Market, by Application, 2018 - 2030 (USD Million)
• Table 124 Kuwait Synthetic Biology Market, End Use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Information Procurement
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 Synthetic Biology Market Segmentation
• Fig. 7 Market Snapshot, 2024
• Fig. 8 Market Trends & Outlook
• Fig. 9 Market Driver Relevance Analysis (Current & Future Impact)
• Fig. 10 Market Restraint Relevance Analysis (Current & Future Impact)
• Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 12 Porter's Five Forces Analysis
• Fig. 13 Global Synthetic Biology Market: Product Key Takeaways
• Fig. 14 Global Synthetic Biology Market: Product Movement Analysis
• Fig. 15 Global Synthetic Biology Market, for Oligonucleotide/Oligo pools and Synthetic DNA, 2018 - 2030 (USD Million)
• Fig. 16 Global Synthetic Biology Market, for Enzymes, 2018 - 2030 (USD Million)
• Fig. 17 Global Synthetic Biology Market, for Cloning Technologies Kits, 2018 - 2030 (USD Million)
• Fig. 18 Global Synthetic Biology Market, for Xeno-nucleic acids, 2018 - 2030 (USD Million)
• Fig. 19 Global Synthetic Biology Market, for Chassis Organism, 2018 - 2030 (USD Million)
• Fig. 20 Global Synthetic Biology Market: Technology Key Takeaways
• Fig. 21 Global Synthetic Biology Market: Technology Movement Analysis
• Fig. 22 Global Synthetic Biology Market, for PCR, 2018 - 2030 (USD Million)
• Fig. 23 Global Synthetic Biology Market, for Genome Editing, 2018 - 2030 (USD Million)
• Fig. 24 Global Synthetic Biology Market, for NGS, 2018 - 2030 (USD Million)
• Fig. 25 Global Synthetic Biology Market, for Bioprocessing Technology, 2018 - 2030 (USD Million)
• Fig. 26 Global Synthetic Biology Market, for Others, 2018 - 2030 (USD Million)
• Fig. 27 Global Synthetic Biology Market: Application Key Takeaways
• Fig. 28 Global Synthetic Biology Market, Application Movement Analysis
• Fig. 29 Global Synthetic Biology Market, for Healthcare, 2018 - 2030 (USD Million)
• Fig. 30 Global Synthetic Biology Market, for Clinical, 2018 - 2030 (USD Million)
• Fig. 31 Global Synthetic Biology Market, for Bio/Pharmaceuticals, 2018 - 2030 (USD Million)
• Fig. 32 Global Synthetic Biology Market, for Diagnostics, 2018 - 2030 (USD Million)
• Fig. 33 Global Synthetic Biology Market, for Non-Clinical, 2018 - 2030 (USD Million)
• Fig. 34 Global Synthetic Biology Market, for Non-Healthcare, 2018 - 2030 (USD Million)
• Fig. 35 Global Synthetic Biology Market, for Biotech Crops, 2018 - 2030 (USD Million)
• Fig. 36 Global Synthetic Biology Market, for Specialty Chemiclas, 2018 - 2030 (USD Million)
• Fig. 37 Global Synthetic Biology Market, for Bio-fuels, 2018 - 2030 (USD Million)
• Fig. 38 Global Synthetic Biology Market, for Others, 2018 - 2030 (USD Million)
• Fig. 39 Global Synthetic Biology Market: End Use Movement Analysis
• Fig. 40 Global Synthetic Biology Market, for Biotechnology and Pharmaceutical Companies, 2018 - 2030 (USD Million)
• Fig. 41 Global Synthetic Biology Market, for Academic & Research Institutes, 2018 - 2030 (USD Million)
• Fig. 42 Global Synthetic Biology Market, for Others, 2018 - 2030 (USD Million)
• Fig. 43 Regional Marketplace: Key Takeaways
• Fig. 44 Regional Outlook, 2024 & 2030
• Fig. 45 North America Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 46 U.S. Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 47 Canada Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 48 Mexico Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 49 Europe Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 50 Germany Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 51 UK Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 52 France Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 53 Italy Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 54 Spain Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 55 Denmark Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 56 Sweden Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 57 Norway Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 58 Asia Pacific Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 59 Japan Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 60 China Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 61 India Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 62 Australia Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 63 South Korea Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 64 Thailand Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 65 Latin America Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 66 Brazil Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 67 Argentina Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 68 Middle East and Africa Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 69 South Africa Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 70 Saudi Arabia Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 71 UAE Synthetic Biology Market, 2018 - 2030 (USD Million)
• Fig. 72 Kuwait Synthetic Biology Market, 2018 - 2030 (USD Million)

Synthetic Biology Market Growth & Trends:

The global synthetic biology market size is expected to reach USD 42.06 billion by 2030, registering a CAGR of 17.30% 2025 to 2030, according to a new report by Grand View Research, Inc. The presence of government and private funding to support research in vaccines and a strong synthetic biologic-based product pipeline in clinical trials are the key driving factors for the market. Synthetic biology processes provide crucial advantages for producing antigen and diagnostic reagents for disease identification, accelerating the speed of vaccine development, and improving overall vaccine performance and yield.

Furthermore, support from government agencies and the presence of several programs are likely to boost the market growth. For instance, in the U.S., COVID-19 vaccine R&D, manufacture, regulation, and purchase have been highly supported by collaboration between federal agencies, including the Biomedical Advanced Research and Development Authority (BARDA), the National Institutes of Health (NIH), DOD, FDA, and others (formerly OWS).

Other factors such as expanding demand in industries such as textiles and nutrition are also contributing to the market growth. Several optimal food production processes have been identified with the help of synthetic biology. In addition, synthetic biology is predicted to aid in the generation of higher agricultural yields and pest control development. It is expected to help in the production of better food yield and pest control management.

The COVID-19 pandemic is anticipated to positively impact market growth. Synthetic biology has been highlighted as a means to accelerate vaccine development by the National Institute of Health in the U.S. Therefore, synthetic biology labs and companies have been actively utilizing this technology to combat the COVID-19 pandemic. As a result, the usage of these technologies is projected to increase during the outbreak.

The growing demand for personalized medicine is expected to majorly drive market growth during the coming years. The use of engineered novel proteins for use as therapeutics has demonstrated synthetic biology in the medical segment. These proteins are designed with some modified protein structure to get the desirable properties required for the treatment. For instance, researchers are developing a therapeutic enzyme candidate that is GI-stable and can be given via oral route to treat Phenylketonuria (PKU).

On the other hand, synthetic biology has raised a few concerns regarding biosecurity and biosafety. Exposure to these products may cause unknown hazards to public health and the environment. To prevent such issues, countries of Europe, the Americas, and Asia have formulated policies to manage the application of synthetic biology techniques in basic & applied research.

Synthetic Biology Market Report Highlights:

• By technology, the PCR segment held the largest share of the market. This is attributed to the accelerated development in modern life science, with PCR technology being widely employed in numerous fields of medical research, virus detection, and the food & beverage industry
• The genome-editing segment is expected to grow steadily during the forecast period. It enables researchers to modify the DNA of various organisms, including plants, bacteria, and animals, and their demand is expected to skyrocket in the coming years
• By product, Oligonucleotide and Synthetic DNA is anticipated to have the larger market share in 2030. The falling price of synthesis and increasing requirement for synthetic DNA, RNA, and genes that are employed in numerous applications contribute to the segment growth
• By application, the healthcare segment held a larger global market share. This is attributed to an increase in drug screening and discovery. Moreover, the use of synthetic biology can reduce the cost of drug discovery and propel market growth
• By end-user, the biotechnology and pharmaceutical companies segment held a larger share in 2024, owing to the growing availability of modern research facilities, favorable legislation, and government assistance and funding
• North America was positioned as the dominant market in 2024 due to the presence of high R&D investment, the availability of technologically advanced healthcare research frameworks, and the development of the synthetic biology market in the region
• The Asia Pacific is expected to witness considerable growth in the future owing to the rising development of personalized treatment and the presence of key players

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Market Definitions
  • 1.2.1. Product Segment
  • 1.2.2. Technology Segment
  • 1.2.3. Application Segment
  • 1.2.4. End Use Segment
• 1.3. Information Analysis
  • 1.3.1. Market Formulation & Data Visualization
• 1.4. Data Validation & Publishing
• 1.5. Information Procurement
  • 1.5.1. Primary Research
• 1.6. Information or Data Analysis
• 1.7. Market Formulation & Validation
• 1.8. Market Model
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Trends and Outlook
• 3.3. Market Dynamics
  • 3.3.1. Increasing Applications of Synthetic Biology
  • 3.3.2. Growing Funding and Assistance from Government and Private Organization
  • 3.3.3. Growing Research and Development Activities in Synthetic Biology
• 3.4. Market Restraint Analysis
  • 3.4.1. Biosafety and Biosecurity Issue
  • 3.4.2. Ethical Issues and Unintended Consequences
• 3.5. Industry Analysis Tools
  • 3.5.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
  • 3.5.2. Porter's Five Forces Analysis
  • 3.5.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Global Synthetic Biology Market: Product Movement Analysis
• 4.3. Global Synthetic Biology Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
• 4.4. Oligonucleotide/Oligo pools and Synthetic DNA
  • 4.4.1. Oligonucleotide/Oligo pools and Synthetic DNA Market, 2018 - 2030 (USD Million)
• 4.5. Enzymes
  • 4.5.1. Enzymes Market, 2018 - 2030 (USD Million)
• 4.6. Cloning Technologies Kits
  • 4.6.1. Cloning Technologies Kits Market, 2018 - 2030 (USD Million)
• 4.7. Xeno-nucleic Acids
  • 4.7.1. Xeno-nucleic Acids Market, 2018 - 2030 (USD Million)
• 4.8. Chassis Organism
  • 4.8.1. Chassis Organism Market, 2018 - 2030 (USD Million)

Chapter 5. Technology Business Analysis

• 5.1. Technology Segment Dashboard
• 5.2. Global Synthetic Biology Market: Technology Movement Analysis
• 5.3. Global Synthetic Biology Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
• 5.4. PCR
  • 5.4.1. PCR Market, 2018 - 2030 (USD Million)
• 5.5. Genome Editing
  • 5.5.1. Genome Editing Market, 2018 - 2030 (USD Million)
• 5.6. NGS
  • 5.6.1. NGS Market, 2018 - 2030 (USD Million)
• 5.7. Bioprocessing Technology
  • 5.7.1. Bioprocessing Technology Market, 2018 - 2030 (USD Million)
• 5.8. Others
  • 5.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Application Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Global Synthetic Biology Market: Application Movement Analysis
• 6.3. Global Synthetic Biology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
• 6.4. Synthetic Biology Market: Technology Movement Analysis
• 6.5. Healthcare
  • 6.5.1. Healthcare Market, 2018 - 2030 (USD Million)
  • 6.5.2. Clinical
    • 6.5.2.1. Clinical Market, 2018 - 2030 (USD Million)
    • 6.5.2.2. Bio/Pharmaceuticals
      • 6.5.2.2.1. Bio/Pharmaceuticals Market, 2018 - 2030 (USD Million)
    • 6.5.2.3. Diagnostics
      • 6.5.2.3.1. Diagnostics Market, 2018 - 2030 (USD Million)
  • 6.5.3. Non-Clinical
    • 6.5.3.1. Non-Clinical Market, 2018 - 2030 (USD Million)
• 6.6. Non-Healthcare
  • 6.6.1. Non-Healthcare Market, 2018 - 2030 (USD Million)
  • 6.6.2. Biotech Crops
    • 6.6.2.1. Biotech Crops Market, 2018 - 2030 (USD Million)
  • 6.6.3. Specialty Chemicals
    • 6.6.3.1. Specialty Chemicals Market, 2018 - 2030 (USD Million)
  • 6.6.4. Bio-Fuels
    • 6.6.4.1. Bio-Fuels Market, 2018 - 2030 (USD Million)
  • 6.6.5. Others
    • 6.6.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Global Synthetic Biology Market: End Use Movement Analysis
• 7.3. Global Synthetic Biology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
• 7.4. Biotechnology and Pharmaceutical Companies
  • 7.4.1. Biotechnology and Pharmaceutical Companies Market, 2018 - 2030 (USD Million)
• 7.5. Academic & Research Institutes
  • 7.5.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
• 7.6. Others
  • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
• 8.3. North America
  • 8.3.1. North America Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Target Disease Prevalence
    • 8.3.2.3. Competitive Scenario
    • 8.3.2.4. Regulatory Framework
    • 8.3.2.5. U.S. Synthetic Biology Market, 2018 - 2030 (USD MILLION)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Target Disease Prevalence
    • 8.3.3.3. Competitive Scenario
    • 8.3.3.4. Regulatory Framework
    • 8.3.3.5. Canada Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Target Disease Prevalence
    • 8.3.4.3. Competitive Scenario
    • 8.3.4.4. Regulatory Framework
    • 8.3.4.5. Mexico Synthetic Biology Market, 2018 - 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Target Disease Prevalence
    • 8.4.2.3. Competitive Scenario
    • 8.4.2.4. Regulatory Framework
    • 8.4.2.5. Germany Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.4.3. UK
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Target Disease Prevalence
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. Regulatory Framework
    • 8.4.3.5. UK Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Target Disease Prevalence
    • 8.4.4.3. Competitive Scenario
    • 8.4.4.4. Regulatory Framework
    • 8.4.4.5. France Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Target Disease Prevalence
    • 8.4.5.3. Competitive Scenario
    • 8.4.5.4. Regulatory Framework
    • 8.4.5.5. Italy Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Target Disease Prevalence
    • 8.4.6.3. Competitive Scenario
    • 8.4.6.4. Regulatory Framework
    • 8.4.6.5. Spain Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Target Disease Prevalence
    • 8.4.7.3. Competitive Scenario
    • 8.4.7.4. Regulatory Framework
    • 8.4.7.5. Denmark Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Target Disease Prevalence
    • 8.4.8.3. Competitive Scenario
    • 8.4.8.4. Regulatory Framework
    • 8.4.8.5. Sweden Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Target Disease Prevalence
    • 8.4.9.3. Competitive Scenario
    • 8.4.9.4. Regulatory Framework
    • 8.4.9.5. Norway Synthetic Biology Market, 2018 - 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Target Disease Prevalence
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. Regulatory Framework
    • 8.5.2.5. Japan Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Target Disease Prevalence
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Regulatory Framework
    • 8.5.3.5. China Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Target Disease Prevalence
    • 8.5.4.3. Competitive Scenario
    • 8.5.4.4. Regulatory Framework
    • 8.5.4.5. India Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Target Disease Prevalence
    • 8.5.5.3. Competitive Scenario
    • 8.5.5.4. Regulatory Framework
    • 8.5.5.5. South Korea Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Target Disease Prevalence
    • 8.5.6.3. Competitive Scenario
    • 8.5.6.4. Regulatory Framework
    • 8.5.6.5. Australia Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.5.7. Thailand
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Target Disease Prevalence
    • 8.5.7.3. Competitive Scenario
    • 8.5.7.4. Regulatory Framework
    • 8.5.7.5. Thailand Synthetic Biology Market, 2018 - 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Target Disease Prevalence
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. Regulatory Framework
    • 8.6.2.5. Brazil Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Target Disease Prevalence
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Regulatory Framework
    • 8.6.3.5. Argentina Synthetic Biology Market, 2018 - 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Target Disease Prevalence
    • 8.7.2.3. Competitive Scenario
    • 8.7.2.4. Regulatory Framework
    • 8.7.2.5. South Africa Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Target Disease Prevalence
    • 8.7.3.3. Competitive Scenario
    • 8.7.3.4. Regulatory Framework
    • 8.7.3.5. Saudi Arabia Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Target Disease Prevalence
    • 8.7.4.3. Competitive Scenario
    • 8.7.4.4. Regulatory Framework
    • 8.7.4.5. UAE Synthetic Biology Market, 2018 - 2030 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Target Disease Prevalence
    • 8.7.5.3. Competitive Scenario
    • 8.7.5.4. Regulatory Framework
    • 8.7.5.5. Kuwait Synthetic Biology Market, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Participant's Overview
  • 9.4.1. Bota Biosciences Inc.
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Codexis, Inc.
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Creative Biogene
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. Creative Enzymes
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Enbiotix, Inc.
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Illumina, Inc.
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Merck KGaA
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. New England Biolabs
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. Eurofins Scientific
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Novozymes
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives
  • 9.4.11. Pareto Bio, Inc.
    • 9.4.11.1. Overview
    • 9.4.11.2. Financial Performance
    • 9.4.11.3. Product Benchmarking
    • 9.4.11.4. Strategic Initiatives
  • 9.4.12. Scarab Genomics, Inc.
    • 9.4.12.1. Overview
    • 9.4.12.2. Financial Performance
    • 9.4.12.3. Product Benchmarking
    • 9.4.12.4. Strategic Initiatives
  • 9.4.13. Synthego
    • 9.4.13.1. Overview
    • 9.4.13.2. Financial Performance
    • 9.4.13.3. Product Benchmarking
    • 9.4.13.4. Strategic Initiatives
  • 9.4.14. Synthetic Genomics Inc.
    • 9.4.14.1. Overview
    • 9.4.14.2. Financial Performance
    • 9.4.14.3. Product Benchmarking
    • 9.4.14.4. Strategic Initiatives
  • 9.4.15. Thermo Fisher Scientific, Inc.
    • 9.4.15.1. Overview
    • 9.4.15.2. Financial Performance
    • 9.4.15.3. Product Benchmarking
    • 9.4.15.4. Strategic Initiatives